|
CAPZB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.04991620636974E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43804976207684E-12 |
| Normal-vs-Stage2 |
4.06689999998822E-06 |
| Normal-vs-Stage3 |
2.57419641158663E-11 |
| Normal-vs-Stage4 |
4.40259995126979E-09 |
| Stage1-vs-Stage2 |
8.164600E-01 |
| Stage1-vs-Stage3 |
5.208400E-01 |
| Stage1-vs-Stage4 |
4.368800E-01 |
| Stage2-vs-Stage3 |
8.712200E-01 |
| Stage2-vs-Stage4 |
7.382200E-01 |
| Stage3-vs-Stage4 |
8.041600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19824158875781E-14 |
| Normal-vs-AfricanAmerican |
1.382590E-03 |
| Normal-vs-Asian |
1.55706999999117E-05 |
| Caucasian-vs-AfricanAmerican |
6.753900E-02 |
| Caucasian-vs-Asian |
2.131200E-01 |
| AfricanAmerican-vs-Asian |
4.305400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.41510161763858E-11 |
| Normal-vs-Female |
7.87148124459236E-14 |
| Male-vs-Female |
6.820800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.55278045766272E-12 |
| Normal-vs-Age(41-60Yrs) |
7.31881222293396E-12 |
| Normal-vs-Age(61-80Yrs) |
2.36211050719248E-12 |
| Normal-vs-Age(81-100Yrs) |
1.447580E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.116200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.134430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.181200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.010000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.481600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.148200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.190600E-01 |
| Classical-VS-Follicular |
2.638200E-01 |
| Classical-VS-Other |
6.165600E-01 |
| Classical-VS-Normal |
5.03197483681106E-12 |
| Tall-VS-Follicular |
5.597000E-01 |
| Tall-VS-Other |
6.936400E-01 |
| Tall-VS-Normal |
1.84719999962724E-07 |
| Follicular-VS-Other |
9.587200E-01 |
| Follicular-VS-Normal |
3.73040043299966E-10 |
| Other-VS-Normal |
4.770400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.25703957932456E-13 |
| Normal-vs-N1 |
4.32289759544346E-11 |
| N0-vs-N1 |
6.534100E-02 |
|
|
